Product Information
LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2267 per EA under NDC 68462067295. Its NADAC has been published 579 times since Sep 2, 2015.
FDA first approved this application on Jun 12, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462067295
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA203164FDA Approved
6/12/2015
TE Code
AB
On Market Since
6/12/2015
Price Statistics
The NADAC for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET has been published 579 times since Sep 2, 2015, and over the history we have for it it has declined 73.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2267 per EA |
|---|---|
| All-time high | $0.9955 (Apr 13, 2016) |
| All-time low | $0.1058 (Nov 20, 2024) |
| 52-week high | $0.2267 |
| 52-week low | $0.1515 |
| Median price | $0.2565 |
| Average price | $0.3546 |
| Largest weekly change | +55.0% (Aug 21, 2024) |
| Weeks tracked | 579 |
| Tracking since | Sep 2, 2015 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2267 per EA (NDC 68462067295), effective Sep 30, 2026.
How has the price of LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET has declined 73.9%. It has been tracked across 579 weekly CMS publications since Sep 2, 2015.
What are the highest and lowest recorded NADAC prices for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
Since Sep 2, 2015, the NADAC for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET has ranged from a low of $0.1058 (Nov 20, 2024) to a high of $0.9955 (Apr 13, 2016), with a median of $0.2565 per EA.
Are there cheaper alternatives to LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVONOR-ETH ESTRAD 0.15-0.03, is $0.1128 per EA — about 50% below LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET.
Who manufactures LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET (NDC 68462067295) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.